Peapack Gladstone Financial Corp Sells 283 Shares of The Clorox Company (NYSE:CLX)

Peapack Gladstone Financial Corp lowered its position in The Clorox Company (NYSE:CLX) by 3.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,904 shares of the company’s stock after selling 283 shares during the quarter. Peapack Gladstone Financial Corp’s holdings in Clorox were worth $1,450,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the third quarter valued at $27,000. Innealta Capital LLC bought a new stake in Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC raised its stake in shares of Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares in the last quarter. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the period. Finally, Family Firm Inc. acquired a new stake in shares of Clorox during the 2nd quarter valued at about $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Up 0.2 %

Shares of NYSE:CLX opened at $164.90 on Monday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm has a market cap of $20.41 billion, a P/E ratio of 57.46, a P/E/G ratio of 3.04 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company’s 50-day moving average price is $163.77 and its two-hundred day moving average price is $151.86.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the firm earned $0.49 earnings per share. Clorox’s revenue was up 27.0% compared to the same quarter last year. As a group, research analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Analysts Set New Price Targets

A number of research analysts have commented on CLX shares. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. JPMorgan Chase & Co. upped their price target on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Barclays boosted their target price on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday, November 1st. Five research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, Clorox presently has an average rating of “Hold” and an average target price of $155.38.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.